246 related articles for article (PubMed ID: 12408714)
1. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
[TBL] [Abstract][Full Text] [Related]
2. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.
Lin L; Shi Q; Nyarko AK; Bastow KF; Wu CC; Su CY; Shih CC; Lee KH
J Med Chem; 2006 Jun; 49(13):3963-72. PubMed ID: 16789753
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies of curcumin analogues.
Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
[TBL] [Abstract][Full Text] [Related]
4. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
6. Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.
Shi Q; Wada K; Ohkoshi E; Lin L; Huang R; Morris-Natschke SL; Goto M; Lee KH
Bioorg Med Chem; 2012 Jul; 20(13):4020-31. PubMed ID: 22672984
[TBL] [Abstract][Full Text] [Related]
7. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
Lin L; Shi Q; Su CY; Shih CC; Lee KH
Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor antagonists and anti-prostate cancer activities of some synthesized steroidal candidates.
Bahashwan SA; Al-Omar MA; Ezzeldin E; Abdalla MM; Fayed AA; Amr AG
Chem Pharm Bull (Tokyo); 2011; 59(11):1363-8. PubMed ID: 22041072
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
Yamakoshi H; Ohori H; Kudo C; Sato A; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
Bioorg Med Chem; 2010 Feb; 18(3):1083-92. PubMed ID: 20060305
[TBL] [Abstract][Full Text] [Related]
11. Antitumor agents 222. Synthesis and anti-androgen activity of new diarylheptanoids.
Ohtsu H; Itokawa H; Xiao Z; Su CY; Shih CC; Chiang T; Chang E; Lee Y; Chiu SY; Chang C; Lee KH
Bioorg Med Chem; 2003 Nov; 11(23):5083-90. PubMed ID: 14604672
[TBL] [Abstract][Full Text] [Related]
12. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
[TBL] [Abstract][Full Text] [Related]
13. "True" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer.
Caboni L; Kinsella GK; Blanco F; Fayne D; Jagoe WN; Carr M; Williams DC; Meegan MJ; Lloyd DG
J Med Chem; 2012 Feb; 55(4):1635-44. PubMed ID: 22280402
[TBL] [Abstract][Full Text] [Related]
14. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation.
Zhou DY; Ding N; Du ZY; Cui XX; Wang H; Wei XC; Conney AH; Zhang K; Zheng X
Mol Med Rep; 2014 Sep; 10(3):1315-22. PubMed ID: 25060817
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents.
Zhang Q; Zhong Y; Yan LN; Sun X; Gong T; Zhang ZR
Bioorg Med Chem Lett; 2011 Feb; 21(3):1010-4. PubMed ID: 21215629
[TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationships of the Antitumor C5-Curcuminoid GO-Y030.
Kohyama A; Yamakoshi H; Hongo S; Kanoh N; Shibata H; Iwabuchi Y
Molecules; 2015 Aug; 20(8):15374-91. PubMed ID: 26305242
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
Bayomi SM; El-Kashef HA; El-Ashmawy MB; Nasr MN; El-Sherbeny MA; Abdel-Aziz NI; El-Sayed MA; Suddek GM; El-Messery SM; Ghaly MA
Eur J Med Chem; 2015 Aug; 101():584-94. PubMed ID: 26197162
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.
Samaan N; Zhong Q; Fernandez J; Chen G; Hussain AM; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2014 Mar; 75():123-31. PubMed ID: 24531225
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative effect of novel curcumin analogues.
Liu B; Xia M; Ji X; Xu L; Dong J
Chem Pharm Bull (Tokyo); 2013; 61(7):757-63. PubMed ID: 23666373
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
Kazui Y; Fujii S; Yamada A; Ishigami-Yuasa M; Kagechika H; Tanatani A
Bioorg Med Chem; 2018 Oct; 26(18):5118-5127. PubMed ID: 30228001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
